![Methyl-L-NIO (hydrochloride) 997elebactam Smiles: C[C@]12O[C@H](C[C@]1(O)C(O)=O)N1C3=C4C(=C5CNC(=O)C5=C3C3=CC=CC=C13)C1=CC=CC=C1N24](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M22774_1635329921.gif?v=1635329922)
Pay in 4 interest-free payments of $30.25 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Smiles: C[C@]12O[C@H](C[C@]1(O)C(O)=O)N1C3=C4C(=C5CNC(=O)C5=C3C3=CC=CC=C13)C1=CC=CC=C1N24
The protection rates of Salvianolic acid Y is 54
4 ± 1
PD-089828 (0
InChi: InChI=1S/C37H48N4O7/c1-25(2)22-33(35(43)39-17-19-47-21-20-46-18-16-38)40-36(44)34(42)32(23-26-10-4-3-5-11-26)41-37(45)48-24-31-29-14-8-6-12-27(29)28-13-7-9-15-30(28)31/h3-15
Methyl-L-NIO (hydrochloride) 997elebactam Smiles: C[C@]12O[C@H](C[C@]1(O)C(O)=O)N1C3=C4C(=C5CNC(=O)C5=C3C3=CC=CC=C13)C1=CC=CC=C1N24Ki: 3. 0 M for nNOS; 10. 0 M for eNOS; 9. 5 M for iNOS Methyl L NIO is a competitive nitric oxide synthase (NOS) inhibitor. Nitric oxide synthase (NOS) catalyzes the NADPH and O2 dependent conversion of L arginine to nitric oxide (NO). Three isoforms, the neuronal (nNOS), endothelial, and inducible, have been identified. Since NO overproduction contributes to various pathophysiological conditions, NOS inhibitors are considered as potential therapeutic
US$ 575.00
US$ 287.50
US$ 499.50
US$ 287.50
US$ 213.00
US$ 35.28
US$ 499.50
US$ 399.50
US$ 625.00
US$ 68.00
US$ 899.50
US$ 38.00
US$ 499.50
US$ 625.00
US$ 68.00
US$ 15.00
US$ 33.00